Cost-effective faster wound healing with a sustained silver-releasing foam dressing in delayed healing leg ulcers - a health-economic analysis
Scanlon, Elizabeth, Karlsmark, Tonny, Leaper, David J., Carter, Kate, Poulsen, Peter B., Hart-Hansen, Kristian and Hahn, Tina W. (2005) Cost-effective faster wound healing with a sustained silver-releasing foam dressing in delayed healing leg ulcers - a health-economic analysis. International Wound Journal, 2, (2), 150-160. (doi:10.1111/j.1742-4801.2005.00083.x).
- Publishers print
Restricted to RAE restricted
The aim of this analysis was to examine the cost-effectiveness of Contreet Foam (A) in comparison with three other commonly used venous leg ulcer treatment protocols: Aquacel Ag (B), Actisorb Silver (C) and Iodoflex (D). A health-economic analysis reflecting the UK treatment practice and cost structure was performed. The analysis was set up to assess the cost of relative wound area reduction over a 4-week treatment period. The model was validated by a UK expert panel consisting of four wound care specialists. To assure that the 4-week model had a realistic link to cost-effectiveness of complete wound healing, a Markov analysis was also performed. Sensitivity analyses were carried out to ensure validity. Protocol A and C proved to be the most effective treatments. The mean relative reduction in wound area after 4 weeks of treatment was 50·2% (protocol A), 23·9% (protocol B), 44·6% (protocol C) and 36·0% (protocol D). Cost-effectiveness ratios showed that protocol A proved to be the most cost-effective treatment, and protocol B the least. The cost per percentage reduction in wound area was £9·50 for protocol A, compared to £16·50–17·60 for the other treatment options. The cost-effectiveness of complete healing (Markov analysis) and sensitivity analyses confirmed these results. Using Contreet Foam instead of the other dressing alternatives may imply savings of £2·2–4·4 million per year to the National Health Service.
|Keywords:||cost-effectiveness, contreet foam, silver, venous leg ulcer, antimicrobial treatment|
|Subjects:||R Medicine > RT Nursing
R Medicine > RL Dermatology
|Divisions:||University Structure - Pre August 2011 > Superseded (SONM) > Superseded (LCHN)
|Date Deposited:||10 Jul 2006|
|Last Modified:||27 Mar 2014 18:25|
|Contact Email Address:||DKTWH@coloplast.com|
|RDF:||RDF+N-Triples, RDF+N3, RDF+XML, Browse.|
Actions (login required)